Loading…

Photoactivation of gold nanoparticles for glioma treatment

Abstract Radiosensitization efficacy of gold nanoparticles (AuNPs) with low energy radiations (88 keV) was evaluated in vitro and in vivo on rats bearing glioma. In vitro, a significant dose-enhancement factor was measured by clonogenic assays after irradiation with synchrotron radiation of F98 glio...

Full description

Saved in:
Bibliographic Details
Published in:Nanomedicine 2013-10, Vol.9 (7), p.1089-1097
Main Authors: Bobyk, Laure, PhD, Edouard, Magali, PhD, Deman, Pierre, PhD, Vautrin, Mathias, PhD, Pernet-Gallay, Karin, PhD, Delaroche, Julie, Adam, Jean-François, PhD, Estève, François, MD, PhD, Ravanat, Jean-Luc, PhD, Elleaume, Hélène, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c544t-8eeddc654a0a0ec59534fab3a13ca05deb32cf55d8521e5ea841f952a3eb99463
cites cdi_FETCH-LOGICAL-c544t-8eeddc654a0a0ec59534fab3a13ca05deb32cf55d8521e5ea841f952a3eb99463
container_end_page 1097
container_issue 7
container_start_page 1089
container_title Nanomedicine
container_volume 9
creator Bobyk, Laure, PhD
Edouard, Magali, PhD
Deman, Pierre, PhD
Vautrin, Mathias, PhD
Pernet-Gallay, Karin, PhD
Delaroche, Julie
Adam, Jean-François, PhD
Estève, François, MD, PhD
Ravanat, Jean-Luc, PhD
Elleaume, Hélène, PhD
description Abstract Radiosensitization efficacy of gold nanoparticles (AuNPs) with low energy radiations (88 keV) was evaluated in vitro and in vivo on rats bearing glioma. In vitro, a significant dose-enhancement factor was measured by clonogenic assays after irradiation with synchrotron radiation of F98 glioma cells in presence of AuNPs (1.9 and 15 nm in diameter). In vivo, 1.9 nm nanoparticles were found to be toxic following intracerebral delivery in rats bearing glioma, whether no toxicity was observed using 15 nm nanoparticles at the same concentration (50 mg/mL). The therapeutic efficacy of gold photoactivation was determined by irradiating the animals after intracerebral infusion of AuNPs. Survival of rats that had received the combination of treatments (AuNPs: 50 mg/mL, 15 Gy) was significantly increased in comparison with the survival of rats that had received irradiation alone. In conclusion, this experimental approach is promising and further studies are foreseen for improving its therapeutic efficacy. From the Clinical Editor These investigators report that gold nanoparticles of the correct size can be used to enhance the effects of irradiation in the context of a glioma model. Since many of the glioma varieties are currently incurable, this or similar approaches may find their way to clinical trials in the near future.
doi_str_mv 10.1016/j.nano.2013.04.007
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00850657v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1549963413001792</els_id><sourcerecordid>1500772763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c544t-8eeddc654a0a0ec59534fab3a13ca05deb32cf55d8521e5ea841f952a3eb99463</originalsourceid><addsrcrecordid>eNp9kU1rFEEQhhtRzIf-AQ8yRz3sWP01sy0ihGCMsGAgem5qe2qSXnum1-7ehfx7Z9i4hxxy6qJ53rfgKcbecag58ObTph5xjLUALmtQNUD7gp1yrczCNEq8PM5SnbCznDcAsgUwr9mJkI2SWphT9vnmPpaIrvg9Fh_HKvbVXQxdNVdvMRXvAuWqj6m6Cz4OWJVEWAYayxv2qseQ6e3je85-X337dXm9WP38_uPyYrVwWqmyWBJ1nWu0QkAgp42Wqse1RC4dgu5oLYXrte6WWnDShEvFe6MFSloboxp5zj4eeu8x2G3yA6YHG9Hb64uVnf8Alhoa3e75xH44sNsU_-4oFzv47CgEHCnusuV6stSKtpETKg6oSzHnRP2xm4Od_dqNnSXY2a8FNa1pp9D7x_7deqDuGPkvdAK-HACajOw9JZudp9FR5xO5Yrvon-__-iTugh-9w_CHHihv4i6Nk2vLbRYW7O184fnAXALw1gj5DxKUoC4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1500772763</pqid></control><display><type>article</type><title>Photoactivation of gold nanoparticles for glioma treatment</title><source>ScienceDirect Journals</source><creator>Bobyk, Laure, PhD ; Edouard, Magali, PhD ; Deman, Pierre, PhD ; Vautrin, Mathias, PhD ; Pernet-Gallay, Karin, PhD ; Delaroche, Julie ; Adam, Jean-François, PhD ; Estève, François, MD, PhD ; Ravanat, Jean-Luc, PhD ; Elleaume, Hélène, PhD</creator><creatorcontrib>Bobyk, Laure, PhD ; Edouard, Magali, PhD ; Deman, Pierre, PhD ; Vautrin, Mathias, PhD ; Pernet-Gallay, Karin, PhD ; Delaroche, Julie ; Adam, Jean-François, PhD ; Estève, François, MD, PhD ; Ravanat, Jean-Luc, PhD ; Elleaume, Hélène, PhD</creatorcontrib><description>Abstract Radiosensitization efficacy of gold nanoparticles (AuNPs) with low energy radiations (88 keV) was evaluated in vitro and in vivo on rats bearing glioma. In vitro, a significant dose-enhancement factor was measured by clonogenic assays after irradiation with synchrotron radiation of F98 glioma cells in presence of AuNPs (1.9 and 15 nm in diameter). In vivo, 1.9 nm nanoparticles were found to be toxic following intracerebral delivery in rats bearing glioma, whether no toxicity was observed using 15 nm nanoparticles at the same concentration (50 mg/mL). The therapeutic efficacy of gold photoactivation was determined by irradiating the animals after intracerebral infusion of AuNPs. Survival of rats that had received the combination of treatments (AuNPs: 50 mg/mL, 15 Gy) was significantly increased in comparison with the survival of rats that had received irradiation alone. In conclusion, this experimental approach is promising and further studies are foreseen for improving its therapeutic efficacy. From the Clinical Editor These investigators report that gold nanoparticles of the correct size can be used to enhance the effects of irradiation in the context of a glioma model. Since many of the glioma varieties are currently incurable, this or similar approaches may find their way to clinical trials in the near future.</description><identifier>ISSN: 1549-9634</identifier><identifier>EISSN: 1549-9642</identifier><identifier>DOI: 10.1016/j.nano.2013.04.007</identifier><identifier>PMID: 23643529</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Brain - pathology ; Brain - radiation effects ; Brain - ultrastructure ; Brain Neoplasms - diagnostic imaging ; Brain Neoplasms - pathology ; Brain Neoplasms - radiotherapy ; Brain tumors ; Cancer ; Cell Line, Tumor ; Cell Survival - radiation effects ; Drug Administration Routes ; Glioma ; Glioma - diagnostic imaging ; Glioma - pathology ; Glioma - radiotherapy ; Gold - radiation effects ; Gold - toxicity ; Gold nanoparticles ; Internal Medicine ; Kaplan-Meier Estimate ; Life Sciences ; Light ; Male ; Medical Physics ; Metal Nanoparticles - radiation effects ; Metal Nanoparticles - toxicity ; Neostriatum - drug effects ; Neostriatum - pathology ; Photoactivation ; Physics ; Radiography ; Rats ; Rats, Inbred F344 ; Subcellular Fractions - metabolism ; Subcellular Fractions - radiation effects ; Synchrotron radiation ; X-Rays</subject><ispartof>Nanomedicine, 2013-10, Vol.9 (7), p.1089-1097</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c544t-8eeddc654a0a0ec59534fab3a13ca05deb32cf55d8521e5ea841f952a3eb99463</citedby><cites>FETCH-LOGICAL-c544t-8eeddc654a0a0ec59534fab3a13ca05deb32cf55d8521e5ea841f952a3eb99463</cites><orcidid>0000-0002-3991-9503 ; 0000-0003-3468-3316</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23643529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00850657$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Bobyk, Laure, PhD</creatorcontrib><creatorcontrib>Edouard, Magali, PhD</creatorcontrib><creatorcontrib>Deman, Pierre, PhD</creatorcontrib><creatorcontrib>Vautrin, Mathias, PhD</creatorcontrib><creatorcontrib>Pernet-Gallay, Karin, PhD</creatorcontrib><creatorcontrib>Delaroche, Julie</creatorcontrib><creatorcontrib>Adam, Jean-François, PhD</creatorcontrib><creatorcontrib>Estève, François, MD, PhD</creatorcontrib><creatorcontrib>Ravanat, Jean-Luc, PhD</creatorcontrib><creatorcontrib>Elleaume, Hélène, PhD</creatorcontrib><title>Photoactivation of gold nanoparticles for glioma treatment</title><title>Nanomedicine</title><addtitle>Nanomedicine</addtitle><description>Abstract Radiosensitization efficacy of gold nanoparticles (AuNPs) with low energy radiations (88 keV) was evaluated in vitro and in vivo on rats bearing glioma. In vitro, a significant dose-enhancement factor was measured by clonogenic assays after irradiation with synchrotron radiation of F98 glioma cells in presence of AuNPs (1.9 and 15 nm in diameter). In vivo, 1.9 nm nanoparticles were found to be toxic following intracerebral delivery in rats bearing glioma, whether no toxicity was observed using 15 nm nanoparticles at the same concentration (50 mg/mL). The therapeutic efficacy of gold photoactivation was determined by irradiating the animals after intracerebral infusion of AuNPs. Survival of rats that had received the combination of treatments (AuNPs: 50 mg/mL, 15 Gy) was significantly increased in comparison with the survival of rats that had received irradiation alone. In conclusion, this experimental approach is promising and further studies are foreseen for improving its therapeutic efficacy. From the Clinical Editor These investigators report that gold nanoparticles of the correct size can be used to enhance the effects of irradiation in the context of a glioma model. Since many of the glioma varieties are currently incurable, this or similar approaches may find their way to clinical trials in the near future.</description><subject>Animals</subject><subject>Brain - pathology</subject><subject>Brain - radiation effects</subject><subject>Brain - ultrastructure</subject><subject>Brain Neoplasms - diagnostic imaging</subject><subject>Brain Neoplasms - pathology</subject><subject>Brain Neoplasms - radiotherapy</subject><subject>Brain tumors</subject><subject>Cancer</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival - radiation effects</subject><subject>Drug Administration Routes</subject><subject>Glioma</subject><subject>Glioma - diagnostic imaging</subject><subject>Glioma - pathology</subject><subject>Glioma - radiotherapy</subject><subject>Gold - radiation effects</subject><subject>Gold - toxicity</subject><subject>Gold nanoparticles</subject><subject>Internal Medicine</subject><subject>Kaplan-Meier Estimate</subject><subject>Life Sciences</subject><subject>Light</subject><subject>Male</subject><subject>Medical Physics</subject><subject>Metal Nanoparticles - radiation effects</subject><subject>Metal Nanoparticles - toxicity</subject><subject>Neostriatum - drug effects</subject><subject>Neostriatum - pathology</subject><subject>Photoactivation</subject><subject>Physics</subject><subject>Radiography</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Subcellular Fractions - metabolism</subject><subject>Subcellular Fractions - radiation effects</subject><subject>Synchrotron radiation</subject><subject>X-Rays</subject><issn>1549-9634</issn><issn>1549-9642</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kU1rFEEQhhtRzIf-AQ8yRz3sWP01sy0ihGCMsGAgem5qe2qSXnum1-7ehfx7Z9i4hxxy6qJ53rfgKcbecag58ObTph5xjLUALmtQNUD7gp1yrczCNEq8PM5SnbCznDcAsgUwr9mJkI2SWphT9vnmPpaIrvg9Fh_HKvbVXQxdNVdvMRXvAuWqj6m6Cz4OWJVEWAYayxv2qseQ6e3je85-X337dXm9WP38_uPyYrVwWqmyWBJ1nWu0QkAgp42Wqse1RC4dgu5oLYXrte6WWnDShEvFe6MFSloboxp5zj4eeu8x2G3yA6YHG9Hb64uVnf8Alhoa3e75xH44sNsU_-4oFzv47CgEHCnusuV6stSKtpETKg6oSzHnRP2xm4Od_dqNnSXY2a8FNa1pp9D7x_7deqDuGPkvdAK-HACajOw9JZudp9FR5xO5Yrvon-__-iTugh-9w_CHHihv4i6Nk2vLbRYW7O184fnAXALw1gj5DxKUoC4</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Bobyk, Laure, PhD</creator><creator>Edouard, Magali, PhD</creator><creator>Deman, Pierre, PhD</creator><creator>Vautrin, Mathias, PhD</creator><creator>Pernet-Gallay, Karin, PhD</creator><creator>Delaroche, Julie</creator><creator>Adam, Jean-François, PhD</creator><creator>Estève, François, MD, PhD</creator><creator>Ravanat, Jean-Luc, PhD</creator><creator>Elleaume, Hélène, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-3991-9503</orcidid><orcidid>https://orcid.org/0000-0003-3468-3316</orcidid></search><sort><creationdate>20131001</creationdate><title>Photoactivation of gold nanoparticles for glioma treatment</title><author>Bobyk, Laure, PhD ; Edouard, Magali, PhD ; Deman, Pierre, PhD ; Vautrin, Mathias, PhD ; Pernet-Gallay, Karin, PhD ; Delaroche, Julie ; Adam, Jean-François, PhD ; Estève, François, MD, PhD ; Ravanat, Jean-Luc, PhD ; Elleaume, Hélène, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c544t-8eeddc654a0a0ec59534fab3a13ca05deb32cf55d8521e5ea841f952a3eb99463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Brain - pathology</topic><topic>Brain - radiation effects</topic><topic>Brain - ultrastructure</topic><topic>Brain Neoplasms - diagnostic imaging</topic><topic>Brain Neoplasms - pathology</topic><topic>Brain Neoplasms - radiotherapy</topic><topic>Brain tumors</topic><topic>Cancer</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival - radiation effects</topic><topic>Drug Administration Routes</topic><topic>Glioma</topic><topic>Glioma - diagnostic imaging</topic><topic>Glioma - pathology</topic><topic>Glioma - radiotherapy</topic><topic>Gold - radiation effects</topic><topic>Gold - toxicity</topic><topic>Gold nanoparticles</topic><topic>Internal Medicine</topic><topic>Kaplan-Meier Estimate</topic><topic>Life Sciences</topic><topic>Light</topic><topic>Male</topic><topic>Medical Physics</topic><topic>Metal Nanoparticles - radiation effects</topic><topic>Metal Nanoparticles - toxicity</topic><topic>Neostriatum - drug effects</topic><topic>Neostriatum - pathology</topic><topic>Photoactivation</topic><topic>Physics</topic><topic>Radiography</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Subcellular Fractions - metabolism</topic><topic>Subcellular Fractions - radiation effects</topic><topic>Synchrotron radiation</topic><topic>X-Rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bobyk, Laure, PhD</creatorcontrib><creatorcontrib>Edouard, Magali, PhD</creatorcontrib><creatorcontrib>Deman, Pierre, PhD</creatorcontrib><creatorcontrib>Vautrin, Mathias, PhD</creatorcontrib><creatorcontrib>Pernet-Gallay, Karin, PhD</creatorcontrib><creatorcontrib>Delaroche, Julie</creatorcontrib><creatorcontrib>Adam, Jean-François, PhD</creatorcontrib><creatorcontrib>Estève, François, MD, PhD</creatorcontrib><creatorcontrib>Ravanat, Jean-Luc, PhD</creatorcontrib><creatorcontrib>Elleaume, Hélène, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Nanomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bobyk, Laure, PhD</au><au>Edouard, Magali, PhD</au><au>Deman, Pierre, PhD</au><au>Vautrin, Mathias, PhD</au><au>Pernet-Gallay, Karin, PhD</au><au>Delaroche, Julie</au><au>Adam, Jean-François, PhD</au><au>Estève, François, MD, PhD</au><au>Ravanat, Jean-Luc, PhD</au><au>Elleaume, Hélène, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Photoactivation of gold nanoparticles for glioma treatment</atitle><jtitle>Nanomedicine</jtitle><addtitle>Nanomedicine</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>9</volume><issue>7</issue><spage>1089</spage><epage>1097</epage><pages>1089-1097</pages><issn>1549-9634</issn><eissn>1549-9642</eissn><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-1</notes><notes>content type line 23</notes><abstract>Abstract Radiosensitization efficacy of gold nanoparticles (AuNPs) with low energy radiations (88 keV) was evaluated in vitro and in vivo on rats bearing glioma. In vitro, a significant dose-enhancement factor was measured by clonogenic assays after irradiation with synchrotron radiation of F98 glioma cells in presence of AuNPs (1.9 and 15 nm in diameter). In vivo, 1.9 nm nanoparticles were found to be toxic following intracerebral delivery in rats bearing glioma, whether no toxicity was observed using 15 nm nanoparticles at the same concentration (50 mg/mL). The therapeutic efficacy of gold photoactivation was determined by irradiating the animals after intracerebral infusion of AuNPs. Survival of rats that had received the combination of treatments (AuNPs: 50 mg/mL, 15 Gy) was significantly increased in comparison with the survival of rats that had received irradiation alone. In conclusion, this experimental approach is promising and further studies are foreseen for improving its therapeutic efficacy. From the Clinical Editor These investigators report that gold nanoparticles of the correct size can be used to enhance the effects of irradiation in the context of a glioma model. Since many of the glioma varieties are currently incurable, this or similar approaches may find their way to clinical trials in the near future.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23643529</pmid><doi>10.1016/j.nano.2013.04.007</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-3991-9503</orcidid><orcidid>https://orcid.org/0000-0003-3468-3316</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1549-9634
ispartof Nanomedicine, 2013-10, Vol.9 (7), p.1089-1097
issn 1549-9634
1549-9642
language eng
recordid cdi_hal_primary_oai_HAL_hal_00850657v1
source ScienceDirect Journals
subjects Animals
Brain - pathology
Brain - radiation effects
Brain - ultrastructure
Brain Neoplasms - diagnostic imaging
Brain Neoplasms - pathology
Brain Neoplasms - radiotherapy
Brain tumors
Cancer
Cell Line, Tumor
Cell Survival - radiation effects
Drug Administration Routes
Glioma
Glioma - diagnostic imaging
Glioma - pathology
Glioma - radiotherapy
Gold - radiation effects
Gold - toxicity
Gold nanoparticles
Internal Medicine
Kaplan-Meier Estimate
Life Sciences
Light
Male
Medical Physics
Metal Nanoparticles - radiation effects
Metal Nanoparticles - toxicity
Neostriatum - drug effects
Neostriatum - pathology
Photoactivation
Physics
Radiography
Rats
Rats, Inbred F344
Subcellular Fractions - metabolism
Subcellular Fractions - radiation effects
Synchrotron radiation
X-Rays
title Photoactivation of gold nanoparticles for glioma treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T09%3A40%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Photoactivation%20of%20gold%20nanoparticles%20for%20glioma%20treatment&rft.jtitle=Nanomedicine&rft.au=Bobyk,%20Laure,%20PhD&rft.date=2013-10-01&rft.volume=9&rft.issue=7&rft.spage=1089&rft.epage=1097&rft.pages=1089-1097&rft.issn=1549-9634&rft.eissn=1549-9642&rft_id=info:doi/10.1016/j.nano.2013.04.007&rft_dat=%3Cproquest_hal_p%3E1500772763%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c544t-8eeddc654a0a0ec59534fab3a13ca05deb32cf55d8521e5ea841f952a3eb99463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1500772763&rft_id=info:pmid/23643529&rfr_iscdi=true